¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Developmental cell."¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
interstitial cell-stimulating hormone
»çÀÌÁú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó, °£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó
interstitial plasma cell pneumonia
»çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
Jurkat cell
Àúı¼¼Æ÷
juvenile cell
À¯¾à¼¼Æ÷
juxtaglomerular cell tumor
Å丮°ç¼¼Æ÷Á¾¾ç, »ç±¸Ã¼¿·¼¼Æ÷Á¾¾ç
Kupffer¡¯s cell
ÄíÆÛ¼¼Æ÷, º°Å«Æ÷½Ä¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
Langerhans cell
¶û°Ô¸£Çѽº¼¼Æ÷
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
large cell acanthoma
Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ´ë¼¼Æ÷±Ø¼¼Æ÷Á¾
large cell carcinoma
´ë¼¼Æ÷¾ÏÁ¾, Å«¼¼Æ÷¾ÏÁ¾
lepra cell
³ªº´¼¼Æ÷
leukemic cell
¹éÇ÷º´¼¼Æ÷
Leydig cell tumor
¶óÀ̵ðÈ÷¼¼Æ÷Á¾¾ç
light cell
¹àÀº¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
myeloid cell
(¢¡marrow cell) °ñ¼ö¼¼Æ÷
myeloma cell
°ñ¼öÁ¾¼¼Æ÷
myoepithelial cell
±ÙÀ°»óÇǼ¼Æ÷
myoid cell
À¯»ç±ÙÀ°¼¼Æ÷
natural killer cell
ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷, ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷
nerve cell
½Å°æ¼¼Æ÷
neural crest cell
½Å°æ´É¼±¼¼Æ÷
neuroendocrine cell
½Å°æ³»ºÐºñ¼¼Æ÷
neuroepithelial cell
½Å°æ»óÇǼ¼Æ÷
neuroglial cell
½Å°æ¾Æ±³¼¼Æ÷
neurosecretory cell
½Å°æºÐºñ¼¼Æ÷
nevus cell
¸ð¹Ý¼¼Æ÷
nodal cell
°áÀý¼¼Æ÷
nucleated cell
À¯ÇÙ¼¼Æ÷
null cell
¹«Ç¥Áö¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
hilus cell tumor
¹®¼¼Æ÷Á¾
hilus cell ³ª
¹®¼¼Æ÷(Ú¦á¬øà).
hodgkins disease,lacunar cell in
¿°ø¼¼Æ÷
hodgkins disease,reed-sternberg cell in
¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
horny cell
°¢Áú¼¼Æ÷
huma immunodeficiency virus,follicular dendritic cell infection by
¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T-cell lymphotrophic virus
Àΰ£ T¼¼Æ÷ ¸²ÇÁ ¿µ¾ç¼º ¹ÙÀÌ·¯½º
human t-cell leukemia virus
ÀÎü T¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hybrid cell
ÇÏÀ̺긮µå¼¼Æ÷
hybridoma, B cell
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hybridoma, T cell
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell like colloidal drop
¼¼Æ÷¾çÄÝ·ÎÀ̵å¾×Àû.
cell line
¼¼Æ÷°è, ¼¼Æ÷ÁÖ
cell line
¼¼Æ÷°è(á¬øàͧ).
cell line
¼¼Æ÷°è(á¬øàͧ).
cell line, established
È®¸³¼¼Æ÷ÁÖ
cell loss
¼¼Æ÷¼Ò½Ç
cell loss factor
¼¼Æ÷¼Ò½Ç°è¼ö
cell lysis
¼¼Æ÷¿ëÇØ
cell mass
¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
cell mass
¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
cell matrix
¼¼Æ÷±âÁú
cell maturation
¼¼Æ÷¼º¼÷
cell mediated hypersensitivity
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
cell mediated immunity
¼¼Æ÷¼º¸é¿ª.
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½